FDA Denies Priority Review For GlaxoSmithKline’s HPV Vaccine Cervarix
Decision could give Merck’s Gardasil an extra four months without HPV vaccine competition.
Decision could give Merck’s Gardasil an extra four months without HPV vaccine competition.